Melittin is a major component of bee venom; it is widely used in traditional medicine because of its therapeutic effects, such as anti-inflammatory effects. However, melittin has limited medical applications owing to its adverse effects, such as high cytotoxicity. In this study, we investigated the physiological activities of various hydrolyzed melittin-derived peptides to eliminate the cytotoxicity of melittin and enhance its efficacy. The 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical scavenging assay confirmed that melittin-derived peptides showed antioxidant activity comparable to that of melittin. Moreover, unlike melittin, which showed high cytotoxicity in the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner salt (MTS) assay, the melittin-derived peptides showed negligible cytotoxicity. Among the melittin-derived peptides, the peptide composed of sequence TTGLPALISWIKRKRQQ (P1) showed inhibitory effects on the mRNA expression of inflammatory cytokines and phosphorylation of IκBα, similar to the effects of melittin in RAW 264.7 cells. Degranulation of RBL-2H3 cells was analyzed using a β-hexosaminidase release assay to confirm the allergenic activity of melittin and P1, which showed remarkably reduced allergenicity of P1 compared to that of melittin. These results indicate that P1 maintained the anti-inflammatory effects of melittin while reducing its cytotoxicity and allergic reactions. In conclusion, the melittin-derived peptide P1 efficiently decreased the adverse effects while maintaining the beneficial effects of melittin, making it suitable for therapeutic applications.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423820 | PMC |
| http://dx.doi.org/10.1080/19768354.2022.2099971 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Intracellular bactericidal activity and action mechanism of MDP1 antimicrobial peptide against VRSA and MRSA in human endothelial cells.
Front Microbiol
August 2024
Venom and Biotherapeutics Molecules Laboratory, Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Introduction: is a prominent cause of postoperative infections, often persisting within host cells, leading to chronic infections. Conventional antibiotics struggle to eliminate intracellular due to poor cell penetration. Antimicrobial peptides are a new hope for tackling intracellular bacteria.
View Article and Find Full Text PDFRapid eradication of vancomycin and methicillin-resistant by MDP1 antimicrobial peptide coated on photocrosslinkable chitosan hydrogel: antibacterial and molecular docking studies.
Front Bioeng Biotechnol
April 2024
Venom and Biotherapeutics Molecules Lab, Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Introduction: Antibiotic resistance and weak bioavailability of antibiotics in the skin due to systemic administration leads to failure in eradication of vancomycin- and methicillin-resistant (VRSA and MRSA)-associated wound infections and subsequent septicemia and even death. Accordingly, this study aimed at designing a photocrosslinkable methacrylated chitosan (MECs) hydrogel coated by melittin-derived peptide 1 (MDP1) that integrated the antibacterial activity with the promising skin regenerative capacity of the hydrogel to eradicate bacteria by burst release strategy.
Methods: The MECs was coated with MDP1 (MECs-MDP1), characterized, and the hydrogel-peptide interaction was evaluated by molecular docking.
Melittin analog p5RHH enhances recombinant adeno-associated virus transduction efficiency.
J Integr Med
January 2024
Faculty of Traditional Chinese Medicine, Naval Medical University, Shanghai 200043, China; Oncology Department of Traditional Chinese Medicine, Changhai Hospital, Naval Medical University, Shanghai 200433, China. Electronic address:
Article Synopsis
- Melittin and its derivatives are being explored to enhance gene delivery systems, particularly in improving the efficiency of recombinant adeno-associated virus (rAAV) vectors for liver cancer treatment.
- Various melittin-derived peptides were tested for their effects on rAAV vector performance, revealing that the p5RHH-rAAV2 vector was notably effective in transducing resistant cell lines and showed promise in both in vitro and in vivo settings.
- The study identified several mechanisms through which melittin analogs enhance gene delivery, particularly emphasizing the role of endosome acidification in facilitating transgene expression.
New N-Terminal Fatty-Acid-Modified Melittin Analogs with Potent Biological Activity.
Int J Mol Sci
January 2024
Animal Nutrition Institute, Chongqing Academy of Animal Science, Chongqing 402460, China.
Melittin, a natural antimicrobial peptide, has broad-spectrum antimicrobial activity. This has resulted in it gaining increasing attention as a potential antibiotic alternative; however, its practical use has been limited by its weak antimicrobial activity, high hemolytic activity, and low proteolytic stability. In this study, N-terminal fatty acid conjugation was used to develop new melittin-derived lipopeptides (MDLs) to improve the characteristics of melittin.
View Article and Find Full Text PDFMelittin derived peptide-drug conjugate, M-DM1, inhibits tumor progression and induces effector cell infiltration in melanoma by targeting M2 tumor-associated macrophages.
Front Immunol
May 2023
Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
Background: Melanoma has the highest mortality rate among all the types of skin cancer. In melanoma, M2-like tumor-associated macrophages (TAMs) are associated with the invasiveness of tumor cells and a poor prognosis. Hence, the depletion or reduction of M2-TAMs is a therapeutic strategy for the inhibition of tumor progression.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!